CURRICULUM VITAE Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi

Transkript

1 Doç Dr Uğur SELEK 1 CURRICULUM VITAE Doç. Dr. Uğur SELEK Amerikan Hastanesi-M.D. Anderson Radyasyon Onkolojisi Merkezi Bölüm Başkanı Teksas Üniversitesi, M. D. Anderson Radyasyon Onkolojisi Öğretim Üyesi EĞITIM Afyon Atatürk İlkokulu Usak Anadolu Lisesi Hacettepe Üniversitesi İngilizce Tıp Fakültesi (HÜTF) HÜTF Radyasyon Onkolojisi Anabilim Dalı İhtisası Klinik Fellow Yoğunluk Ayarlı ve 3-Boyutlu Konformal Radyoterapi Programı, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD Klinik Fellow Yoğunluk Ayarlı ve Stereotaktik Radyoterapi Programı, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD Uzman Doktor, HÜTF Radyasyon Onkolojisi Anabilim Dalı Yard. Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı Yedek Subay, GATA Radyasyon Onkolojisi Anabilim Dalı Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi AKADEMİK HAYAT 1997 Tıp Doktoru, HÜTF 1998 Educational Commission for Foreign Medical Graduates Certification 2001 Radyasyon Onkolojisi Uzmanı, HÜTF Klinik Fellow, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD 2006 Doçent Doktor, HÜTF 2009 Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi

2 Doç Dr Uğur SELEK 2 ÖDÜL 2003 First Annual M. D. Anderson Radiation Oncology Fellow Research Award, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD ÜYELIKLER 1- ASTRO 2- EORTC 3- Türk Radyasyon Onkolojisi Derneği 4- Türk Akciğer Kanseri Derneği 5- M. D. Anderson Cancer Center Alumni and Faculty Association ULUSLARARASI KONGRE GÖREV VE HAKEMLİKLERİ American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi, Şikago, ABD, Kasım 1-5: Poster Tartışması Moderatörü American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi, Şikago, ABD, Kasım 1-5: Bildiri Hakemi American Society of Radiation Oncology (ASTRO), 50. Yıllık Kongresi, Boston, ABD, Eylül 21-25: Bildiri Hakemi ULUSLARARASI DERGİ HAKEMLİKLERİ 1. International Journal of Radiation Oncology Biology Physics (ISSN: ) 2. Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck (ISSN: ) 3. Journal of Experimental & Clinical Cancer Research (ISSN: ) 4. Tohoku Journal Of Experimental Medicine (ISSN: ) 5. Journal of Palliative Medicine (ISSN: ) 6. Journal of the National Medical Association (ISSN: ) 7. Uluslararası Hematoloji-Onkoloji Dergisi (ISSN: X) 8. Turkiye Klinikleri Tıp Bilimleri Dergisi (ISSN: ) YAYINLAR Uluslararası Kitap Bölümleri 1. Selek U, Chang EL. Skull base and posterior fossa. In: Chao KSC, Ozyigit O, Apisarnthanarax S, editors. Practical essentials of Intensity Modulated Radiation Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; pp Ozyigit G, Selek U. Oral cavity. In: Chao KSC, Ozyigit O, Apisarnthanarax S, editors. Practical essentials of Intensity Modulated Radiation Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; pp Science Citation Index Expanded Yayınları

3 Doç Dr Uğur SELEK 3 1- Zorlu F, Selek U, Kiratli H. Initial Results Of Fractionated Cyberknife Radiosurgery For Uveal Melanoma. J Neurooncol Feb 22. [Epub ahead of print] 2- Topkan E, Yildirim BA, Selek U, Yavuz MN. Cranial Prophylactic Irradiation in Locally Advanced Non-Small Cell Lung Carcinoma: Current Status and Future Perspectives. Oncology. 2009;76(3): Epub 2009 Feb Zorlu AF, Selek U, Emri S, Gurkaynak M, Akyol FH. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Yonsei Med J Aug 30;49(4): Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc May;100(5): Atahan IL, Ozyigit G, Yildiz F, Gurkaynak M, Selek U, Sari S, Hayran M. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy. Breast J May-Jun;14(3): Epub 2008 Apr Gultekin M, Selek U, Ozyigit G, Cengiz M, Yavas O, Yildiz F. Boost dose back again in elderly. J Clin Oncol Dec 20;25(36):5843-4; author reply Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncol. 2008;47(2): Cengiz M, Yildiz F, Selek U, Ozyigit G. Comment on "computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachtherapy: results of a prospective trial and preliminary guidelines for standardized contours" by Viswanathan et Al. (Int j radiat oncol biol phys 2007;68: , 2007). Int J Radiat Oncol Biol Phys Nov 1;69(3):963; author reply Yazici G, Selek U, Yildiz F, Ozyigit G, Cengiz M. Is mastectomy superior to breast-conserving treatment for young women? In regard to Coulombe et Al. (Int j radiat oncol biol phys 2007;67: ). Int J Radiat Oncol Biol Phys Oct 1;69(2):640; author reply 640.

4 Doç Dr Uğur SELEK Cengiz M, Gürdalli S, Selek U, Yildiz F, Saglam Y, Ozyar E, Atahan IL. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation. Int J Radiat Oncol Biol Phys Feb 1;70(2): Epub 2007 Sep Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on "Cranial location of level II lymph nodes in laryngeal cancer: implications for elective nodal target volume delineation": in regard to Braam et al. (Int J Radiat Oncol Biol Phys 2007;67: ). Int J Radiat Oncol Biol Phys Aug 1;68(5):1582-3; author reply Selek U, Zorlu F, Hurmuz P, Cengiz M, Turker A, Soylemezoglu F, Gurkaynak M. Craniospinal radiotherapy in adult medulloblastoma. Strahlenther Onkol May;183(5): Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer Jul-Aug;17(4): Epub 2007 Mar Varan A, Akyüz C, Akalan N, Atahan L, Söylemezoglu F, Selek U, Yalçin B, Kutluk T, Büyükpamukçu M. Astrocytic tumors in children: treatment results from a single institution. Childs Nerv Syst Mar;23(3): Epub 2006 Oct Cengiz M, Cetin E, Yildiz F, Selek U, Aydinkarahaliloglu E. Change in blood chemistry may explain higher toxicity of total body irradiation for bone marrow transplantation. Med Hypotheses. 2007;68(3): Epub 2006 Oct Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol Oct;81(1): Epub 2006 Sep Yildiz F, Genc M, Akyurek S, Cengiz M, Ozyar E, Selek U, Atahan IL. Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc Jul;98(7): Akyol F, Selek U, Ozyigit G, Onal C, Akdogan B, Karabulut E, Ozen H. Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. J Natl Med Assoc Jul;98(7):

5 Doç Dr Uğur SELEK Yazici G, Yildiz F, Cengiz M, Ozyigit G, Selek U, Genç M, Atahan IL. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys 2006;64: ). Int J Radiat Oncol Biol Phys Aug 1;65(5):1594; author reply Cağlar K, Varan A, Akyüz C, Selek U, Kutluk T, Yalçin B, Atahan IL, Büyükpamukçu M. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol Jun;28(6): Atahan L, Yildiz F, Selek U, Sari S, Gurkaynak M. Postoperative radiotherapy in the treatment of male breast carcinoma: a single institute experience. J Natl Med Assoc Apr;98(4): Zorlu F, Selek U, Onal C, Söylemezoğlu F, Gurkaynak M. Postoperative radiotherapy in cranial ganglioglioma. J Neurooncol May;77(3): Zorlu F, Selek U, Soylemezoglu F, Oge K. Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone. J Neurooncol Jan;76(2): Zorlu F, Selek U, Akyuz C, Ozturk A, Soylemezoglu F, Akalan N. Spinal seeding of a pilocytic astrocytoma following multiple subtotal resections. Pediatr Neurosurg Sep-Oct;41(5): Zorlu F, Selek U, Ulger S, Donmez T, Erden E. Paraganglioma in sella. J Neurooncol Jul;73(3): Akyol F, Ozyigit G, Selek U, Karabulut E. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol Jul;48(1): Selek U, Cengiz M, Ozyigit G, Yildiz F, Lale Atahan I. Comment on: "HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome" [Radiother Oncol 2005;74:31-35, Shrivastava et al.]. Radiother Oncol Jul;76(1):107-8; author reply Cengiz M, Selek U, Genç M, Aydinkarahaliloglu E, Yildiz F. Comment on "Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and histopathologic findings in 33 patients with operable cervix carcinoma". Radiother Oncol Jun;75(3):367-8; author reply

6 Doç Dr Uğur SELEK Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery May;56(5):936-45; discussion Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on: "Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy" Wu et al. [Radiother Oncol 2004; 71: ]. Radiother Oncol Jan;74(1):78; author reply Cengiz M, Selek U, Yildiz F, Sari S. Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced nonsmall cell lung cancer: a clinical Phase II trial" Radiother Oncol 71(2): , 2004 by Dr Chen et al.]. Radiother Oncol Jan;74(1):76-7; author reply Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL. Treatment results of 59 young patients with nasopharyngeal carcinoma. Int J Pediatr Otorhinolaryngol Feb;69(2): Yildiz F, Kars A, Cengiz M, Yildiz O, Akyürek S, Selek U, Ozyigit G, Atahan IL. 1,25-Dihydroxy vitamin D3: can it be an effective therapeutic option for aggressive fibromatosis. Med Hypotheses. 2005;64(2): Rosenthal DI, Barker JL Jr, El-Naggar AK, Glisson BS, Kies MS, Diaz EM Jr, Clayman GL, Demonte F, Selek U, Morrison WH, Ang KK, Chao KS, Garden AS. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer Dec 1;101(11): Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys Jul 15;59(4): Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys Jul 15;59(4): Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys Jul 1;59(3):

7 Doç Dr Uğur SELEK Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F. Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol Apr;71(1): Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH. Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer Apr 1;100(7): Review. 40- Selek U, Lee A, Levy L, Kuban DA. Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys Nov 15;57(4):963-7.